Literature DB >> 30807179

Proteomic Analysis Reveals Novel Mechanisms by Which Polychlorinated Biphenyls Compromise the Liver Promoting Diet-Induced Steatohepatitis.

Josiah E Hardesty, Banrida Wahlang, K Cameron Falkner, Hongxue Shi, Jian Jin, Yun Zhou, Daniel W Wilkey, Michael L Merchant, Corey T Watson, Wenke Feng, Andrew J Morris1, Bernhard Hennig1, Russell A Prough, Matthew C Cave2,3.   

Abstract

Environmental pollution contributes to fatty liver disease pathogenesis. Polychlorinated biphenyl (PCB) exposures have been associated with liver enzyme elevation and suspected steatohepatitis in cohort studies. Male mice treated with the commercial PCB mixture, Aroclor 1260 (20 mg/kg), and fed high fat diet (HFD) for 12 weeks developed steatohepatitis. Receptor-based modes of action including inhibition of the epidermal growth factor (EGF) receptor were previously proposed, but other mechanisms likely exist. Objectives were to identify and validate the pathways, transcription factors, and mechanisms responsible for the steatohepatitis associated with PCB and HFD coexposures. Comparative proteomics analysis was performed in archived mouse liver samples from the aforementioned chronic exposure study. Pathway and transcription factor analysis (TFA) was performed, and selected results were validated. Liver proteomics detected 1103 unique proteins. Aroclor 1260 upregulated 154 and downregulated 93 of these. Aroclor 1260 + HFD coexposures affected 55 pathways including glutathione metabolism, intermediary metabolism, and cytoskeletal remodeling. TFA of Aroclor 1260 treatment demonstrated alterations in the function of 42 transcription factors including downregulation of NRF2 and key nuclear receptors previously demonstrated to protect against steatohepatitis (e.g., HNF4α, FXR, PPARα/δ/γ, etc.). Validation studies demonstrated that Aroclor 1260 significantly reduced HNF4α protein levels, while Aroclor 1260 + HFD reduced expression of the HNF4α target gene, albumin, in vivo. Aroclor 1260 attenuated EGF-dependent HNF4α phosphorylation and target gene activation in vitro. Aroclor 1260 reduced levels of NRF2, its target genes, and glutathione in vivo. Aroclor 1260 attenuated EGF-dependent NRF2 upregulation, in vitro. Aroclor 1260 indirectly activated hepatic stellate cells in vitro via induction of hepatocyte-derived TGFβ. PCB exposures adversely impacted transcription factors regulating liver protection, function, and fibrosis. PCBs, thus, compromised the liver by reducing its protective responses against nutritional stress to promote diet-induced steatohepatitis. The identified mechanisms by which environmental pollutants influence fatty liver disease pathogenesis require confirmation in humans.

Entities:  

Keywords:  Aroclor 1260; EGFR; HNF4α; TASH; liver; metabolism; polychlorinated biphenyl; steatohepatitis

Mesh:

Substances:

Year:  2019        PMID: 30807179      PMCID: PMC7059562          DOI: 10.1021/acs.jproteome.8b00886

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  42 in total

Review 1.  Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysis.

Authors:  Siddharth Singh; Rohan Khera; Alina M Allen; M Hassan Murad; Rohit Loomba
Journal:  Hepatology       Date:  2015-10-01       Impact factor: 17.425

2.  Activation of Keap1/Nrf2 signaling pathway by nuclear epidermal growth factor receptor in cancer cells.

Authors:  Longfei Huo; Chia-Wei Li; Tzu-Hsuan Huang; Yung Carmen Lam; Weiya Xia; Chun Tu; Wei-Chao Chang; Jennifer L Hsu; Dung-Fang Lee; Lei Nie; Hirohito Yamaguchi; Yan Wang; Jingyu Lang; Long-Yuan Li; Chung-Hsuan Chen; Lopa Mishra; Mien-Chie Hung
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

Review 3.  Mechanisms of hepatic stellate cell activation.

Authors:  Takuma Tsuchida; Scott L Friedman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-10       Impact factor: 46.802

4.  Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.

Authors:  Arun J Sanyal; Naga Chalasani; Kris V Kowdley; Arthur McCullough; Anna Mae Diehl; Nathan M Bass; Brent A Neuschwander-Tetri; Joel E Lavine; James Tonascia; Aynur Unalp; Mark Van Natta; Jeanne Clark; Elizabeth M Brunt; David E Kleiner; Jay H Hoofnagle; Patricia R Robuck
Journal:  N Engl J Med       Date:  2010-04-28       Impact factor: 91.245

Review 5.  Metabolism disrupting chemicals and metabolic disorders.

Authors:  Jerrold J Heindel; Bruce Blumberg; Mathew Cave; Ronit Machtinger; Alberto Mantovani; Michelle A Mendez; Angel Nadal; Paola Palanza; Giancarlo Panzica; Robert Sargis; Laura N Vandenberg; Frederick Vom Saal
Journal:  Reprod Toxicol       Date:  2016-10-17       Impact factor: 3.143

6.  A compromised liver alters polychlorinated biphenyl-mediated toxicity.

Authors:  Banrida Wahlang; Jordan T Perkins; Michael C Petriello; Jessie B Hoffman; Arnold J Stromberg; Bernhard Hennig
Journal:  Toxicology       Date:  2017-02-02       Impact factor: 4.221

7.  Transcription factor binding site enrichment analysis predicts drivers of altered gene expression in nonalcoholic steatohepatitis.

Authors:  April D Lake; Alexandria L Chaput; Petr Novak; Nathan J Cherrington; Catharine L Smith
Journal:  Biochem Pharmacol       Date:  2016-11-09       Impact factor: 5.858

8.  Polychlorinated biphenyls, lead, and mercury are associated with liver disease in American adults: NHANES 2003-2004.

Authors:  Matt Cave; Savitri Appana; Mihir Patel; Keith Cameron Falkner; Craig J McClain; Guy Brock
Journal:  Environ Health Perspect       Date:  2010-12       Impact factor: 9.031

9.  Potential effects of polychlorinated biphenyls (PCBs) and selected organochlorine pesticides (OCPs) on immune cells and blood biochemistry measures: a cross-sectional assessment of the NHANES 2003-2004 data.

Authors:  Berrin Serdar; William G LeBlanc; Jill M Norris; L Miriam Dickinson
Journal:  Environ Health       Date:  2014-12-16       Impact factor: 5.984

10.  Proteomic profiling of cellular steatosis with concomitant oxidative stress in vitro.

Authors:  Khalida Ann Lockman; Varanand Htun; Rohit Sinha; Philipp Treskes; Leonard J Nelson; Sarah F Martin; Sophie M Rogers; Thierry Le Bihan; Peter C Hayes; John N Plevris
Journal:  Lipids Health Dis       Date:  2016-07-02       Impact factor: 3.876

View more
  5 in total

Review 1.  Mechanisms of Environmental Contributions to Fatty Liver Disease.

Authors:  Banrida Wahlang; Jian Jin; Juliane I Beier; Josiah E Hardesty; Erica F Daly; Regina D Schnegelberger; K Cameron Falkner; Russell A Prough; Irina A Kirpich; Matthew C Cave
Journal:  Curr Environ Health Rep       Date:  2019-09

2.  Polychlorinated biphenyls altered gut microbiome in CAR and PXR knockout mice exhibiting toxicant-associated steatohepatitis.

Authors:  Banrida Wahlang; Nicholas C Alexander; Xiaohong Li; Eric C Rouchka; Irina A Kirpich; Matthew C Cave
Journal:  Toxicol Rep       Date:  2021-03-10

3.  Combined exposure to polychlorinated biphenyls and high-fat diet modifies the global epitranscriptomic landscape in mouse liver.

Authors:  Carolyn M Klinge; Kellianne M Piell; Belinda J Petri; Liqing He; Xiang Zhang; Jianmin Pan; Shesh N Rai; Kalina Andreeva; Eric C Rouchka; Banrida Wahlang; Juliane I Beier; Matthew C Cave
Journal:  Environ Epigenet       Date:  2021-09-17

4.  Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity.

Authors:  Jian Jin; Banrida Wahlang; Hongxue Shi; Josiah E Hardesty; K Cameron Falkner; Kimberly Z Head; Sudhir Srivastava; Michael L Merchant; Shesh N Rai; Matthew C Cave; Russell A Prough
Journal:  Med Chem Res       Date:  2020-06-07       Impact factor: 1.965

5.  Effect of Epidermal Growth Factor Treatment and Polychlorinated Biphenyl Exposure in a Dietary-Exposure Mouse Model of Steatohepatitis.

Authors:  Josiah E Hardesty; Banrida Wahlang; Russell A Prough; Kim Z Head; Daniel Wilkey; Michael Merchant; Hongxue Shi; Jian Jin; Matthew C Cave
Journal:  Environ Health Perspect       Date:  2021-03-31       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.